MedPath

Managing burnout with non-invasive neuromodulatio

Not Applicable
Completed
Conditions
Attention deficits in burnout
Mental and Behavioural Disorders
Registration Number
ISRCTN94275121
Lead Sponsor
Vrije Universiteit Brussel
Brief Summary

2020 results in preprint in https://doi.org/10.12688/f1000research.21831.1 (added 03/06/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
16
Inclusion Criteria

1. Score of > 4 on the Dutch version of the Maslach Burnout Scale (MBS)

Exclusion Criteria

1. Excessive drug or alcohol use
2. Epilepsy
3. Depression
4. Bipolar syndrome
5. Chronic fatigue syndrome or any other history of psychiatric or neurological disorders
6. Implanted neurostimulator or pace-maker
7. Drugs interacting directly with the NMDA receptors
8. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Attention measured using RBANS at baseline and after 3 weeks of stimulation
Secondary Outcome Measures
NameTimeMethod
<br> At baseline and after 3 weeks of stimulation:<br> 1. Burnout measured using MBS<br> 2. Depression measured using BDI<br> 3. Quality of Life measured using QoL<br> 4. Attention measured using RBANS Attention Index<br> 5. Vigilance measured using D2 (s-score)<br> 6. Central executive measured using Inhibition and shifting, Stroop III, TMT B, WCST<br> 7. Processing speed (updating and control) measured using TMT A, Stroop I and II, D2 (Gz, F%, Gz – F)<br> 8. Phonological loop measured using RBANS Language Index<br> 9. BNTmeasured using Semantic fluency tasks<br> 10. Visuospatial sketchpad measured using Raven and RBANS Visuospatial Index<br> 11. Encoding measured using RBANS Immediate Memory Index<br> 12. Retrieval measured using RBANS Recent Memory Index<br>
© Copyright 2025. All Rights Reserved by MedPath